chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I went into the pharmacy with an appointment to get my Flu shot.  They called me back and gave me a vacination without asking me anything or what shot I was here for. They then asked me if this was my first or second t.  I tdose, I told them I was there just for a flu shot as the paper stated.  I have already had my two shots of maderna  and now they have given me a shot of pfizer due to their neglegence.
Diarrhea, hot flashes, chills all over body and in isolated areas, numbness/tingling in face/cheeks towards ears and neck.
Pt had a positive COVID test on 8/27/21 at a pharmacy; was admitted to hospital from 8/27/21 - 9/17/21; he was treated with remdesivir, baricitinib, dexamethasone; dc'd; back to hosp on 10/17/21 with worsening SOB; on 4 L O2 via NC; CXR showed worsening pulmonary opacities; treated with ABX; admitted with pneumonia; COVID test was now negative; respiratory status did not improve; treated with steroids; developed acute respiratory needs, transitioned to Vapotherm and transferred to PCU; weaned from Vapotherm to O2 via NC; worsening thrombocytopenia; PT worked with patient and he passed out from being to weak to do PT; planned to send pt home with hospice, but pt expired in the hosp before able to go home
Shingles; Rash on back; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th December 2020, the patient received Shingrix. On 18th December 2020, 2 days after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional details were procided as follows: The age at vaccination was not reported. The age group of the patient was not reported but selected as an adult as per vaccine indication. Then reporter stated that, received dose of Shingrix on wednesday and by friday night had rash on back and shingles. The reporter stated that, rash was not listed as side effect but no doubt, had shingles.
Within 24 hours, muscle fatigue, cold symptoms, shortness of breath, fever.  Progressing on second day to low pulse ox reading (92%) and continued same symptoms.  Evening was extreme left eye pain, unable to touch, ice pack did not help.  Symptoms lessened over next two days but vision was blurry and both eyes irritated.  Developed a sty in left eye on Sunday which is still present.
13 Year old male with previous h/o GBS (7 yrs ago), no neurologic sequelae was given MCV4 on 4/24/07. No reactions after vaccine noted. 2/5/09-per CDC remove GBS.
no additional AE information; Caller reported expired dose of PROQUAD administered to patient.  Product did not experience any temperature excursions.  Read supported statement.  No additional AE information.  No PQC.; Information has been received from an unspecified reporter, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 01-APR-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) 0.5 ml, once, lot # t029104, expiration date on 23-FEB-2022 (administration route was not reported) for prophylaxis. No adverse effects were reported.
330 about 7PM started coughing-hard to breath tickle in throat-wheezing really bad-burned in chest felt heavy;propped up to breath-didn't get worse so slept; next day better eyes puffy-felt exhausted felt better 1 1/2 hr;
he noticed swelling on the upper L side of his body "underneath arm pit, by ribs"; he noticed pain on the L side of his body; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A 27-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration, administered in left arm on 04Jun2021 at 14:00 (at the age of 27-years-old) as single dose for covid-19 immunisation. The patient did not receive additional vaccines on the same date of the Pfizer Suspect. The patient had no relevant medical history. The patient family medical history relevant to events was reported as her mother has high blood pressure. The patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162B2 via an unspecified route of administration, administered in left arm on 14May2021 (at the age of 27-years-old) as single dose for covid-19 immunisation. On 05Jun2021, the patient experienced pain on the upper left side of his body and resolved the following day. On 08Jun2021, he noticed swelling on the upper left side of his body underneath arm pit, by ribs; on the left side of his body that has continued. After he woke today, he took pictures, and he saw the difference. He noticed the swelling after he got out of the shower and he felt it throughout the day. He is chubby but the other side of his body was not the same. It was like he had a roll with sweat underneath it. He was calling to see if this is a serious concern, and he will go to the doctor after work if he needs to. The outcome of event pain was resolved on 06Jun2021 and for another event it was not resolved.  Information on the batch/lot number has been requested.
pain underneath her left arm; looks like a sunburn; a rash half way down her neck to torso; swollen on the injection site (left arm); rash around injection site that but doesn't itch; terrible headache; joints hurts; low grade fever; nausea; felt very tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain underneath her left arm), SUNBURN (looks like a sunburn), RASH (a rash half way down her neck to torso), HEADACHE (terrible headache) and ARTHRALGIA (joints hurts) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 057F21A / 037F21A, J31L20A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Dec-2021, the patient experienced HEADACHE (terrible headache), ARTHRALGIA (joints hurts), PYREXIA (low grade fever), NAUSEA (nausea) and FATIGUE (felt very tired). On 04-Dec-2021, the patient experienced PAIN IN EXTREMITY (pain underneath her left arm), SUNBURN (looks like a sunburn), RASH (a rash half way down her neck to torso), VACCINATION SITE SWELLING (swollen on the injection site (left arm)) and VACCINATION SITE RASH (rash around injection site that but doesn't itch). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) on 04-Dec-2021 at a dose of 1 dosage form. On 03-Dec-2021, HEADACHE (terrible headache), ARTHRALGIA (joints hurts), PYREXIA (low grade fever), NAUSEA (nausea) and FATIGUE (felt very tired) had resolved. At the time of the report, PAIN IN EXTREMITY (pain underneath her left arm), SUNBURN (looks like a sunburn), RASH (a rash half way down her neck to torso), VACCINATION SITE SWELLING (swollen on the injection site (left arm)) and VACCINATION SITE RASH (rash around injection site that but doesn't itch) had not resolved.            No concomitant medications provided by reporter.
Left side of neck swollen (like visibly swollen) from mid neck down to bottom; Tenderness; a little painful (pain goes down to collar bone)/achy feeling; able to feel the swollen lymph nodes; Skin warm at touch; Some pain lifting left arm at injection site; This is a spontaneous report from a contactable other healthcare professional. A 35-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EL9267, Expiration date: unknown), via an unspecified route of administration, administered in Arm Left on 17Feb2021 15:15 (age at vaccination was 35years) as dose 1, single for COVID-19 immunization. The patient's medical history included attention deficit hyperactivity disorder, anxiety, depression, hypertension, migraine, blood cholesterol increased. Concomitant medication included lisdexamfetamine mesilate (VYVANSE), bupropion hydrochloride, loratadine, omeprazole, amitriptyline, alprazolam (XANAX), metoprolol succinate, ropinirole hydrochloride (REQUIP), topiramate and topiramate (TOPAMAX) start and stop date were not reported. Patient received Flu shot vaccines around the time of Pfizer-BioNTech COVID-19 Vaccine vaccination. Patient did not receive any recent vaccines for any other conditions prior to the event being reported. The patient did not have any known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Post vaccination, the patient was not diagnosed with COVID-19. On 18Feb2021 at 16:30 the patient experienced left side of neck swollen (like visibly swollen) from mid neck down to bottom, tenderness, a little painful (pain goes down to collar bone)/achy feeling, able to feel the swollen lymph nodes, skin warm at touch and some pain lifting left arm at injection site. Patient mentioned that no rash at site or anywhere else on body and no problems to breath or swallow. The patient underwent lab tests and procedures which included body temperature which showed increased result on 18Feb2021. A 35-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EN6207, Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 10Mar2021 14:00 as dose 2, single for COVID-19 immunization. No treatment was received for the adverse events. The outcome of the events was recovered on an unspecified date in 2021.  Follow-up (14Apr2021 and 07May2021): New information reported from a contactable consumer (patient) included: clinical outcome updated from not recovered to recovered, added historical Vaccine as Flu shot, concomitant medication.  Follow-up attempts completed. No further information expected.
Client 2 yr. 8 month was given Flu vaccine for 3yr old. No adverse reaction reported.
a bad case of balance problems; Information has been received from a lawyer, regarding a case in litigation, and refers to a female patient (pt) of unknown age. No information about the pt's medical history, concurrent conditions and concomitant medications was provided. On or around 04-NOV-2013, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered a bad case of balance problems. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations not present prior to using the suspect product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the pt Plaintiff had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event of a bad case of balance problems was considered to be not recovered. The reporter determined the event to be related to zoster vaccine live (ZOSTAVAX). The event of a bad case of balance problems was considered to be disabling.
Pain in Left side of Neck. Hives, redness and swelling of Neck and Face.
Chills started around 1:30am, very bad headache (I never get headaches), some muscle discomfort,  was unable to sleep. The following day,  very weak, no appetite, nauseous and did vomit several times.  Had to stay in bed pretty much the whole day. Following day -today- feel better but still not 100%- some brain fog.
1/7/2021 21:30 Headache 1/8/2021 0130 until 2330, Fever, body pain
Contracted COVID-19 symptoms (headache, runny nose, dry cough, fatigue) became severe on 6/25/2022, called physician on 6/26, received and began 5 day course of paxlovid on evening of 6/26/2022. Symptoms resolved by 7/1/2022. Tested negative at that time and througth 7/4/2022. On 7/5/2022, began feeling symptoms again, and tested positive for COVID-19 again (rebound case). Let the virus run it's course, and tested positive until 7/12/2022.
Unilateral cleft lip with possible cleft palate in unborn child as diagnosed via fetal ultrasound (3D). 1st vaccination given at 3 weeks of pregnancy, 2nd vaccination given at 7 weeks (time during fetal lip and palate formation). I experienced a 101 degree F fever and body aches after second vaccination dose.
Rec'd vaccines on 12/31/04. Swollen arm - elbow to shoulder, red,sore, sore throat, rash appeared Jan 1. Ate small amount of glitter glue on Jan 1. Was hysterical. Exhibited many neurological symptoms starting Jan 2. Weird hand, finger movements, obsessive compulsive behavior (germs,excess handwashing), high pitched crying/whining, regressive behavior, very emotional (crying,anger,clawing at my face & neck), sore throat. After 2 weeks was also spitting (1000 times/day), licking lips excessively until chapped and wiping mouth on sleeve. Most symptoms improved after 2 courses of antibiotics but still definitely not back to normal.
Ached all over my body, especially left knee and left shoulder. No vomiting, no diarrhea. The aching was subsiding on - 9-15-13, by noon. I am healthy now!
Tested positive for COVID 19; Tested positive for COVID 19; This is a spontaneous report from a contactable consumer. A 38-year-old male patient received second dose of bnt162b2 (BNT162B2, Formulation: Solution for Injection, Batch/Lot number: EW0162) dose 2 via unknown route of administration, administered in Arm Left on 10Apr2021 10:00 (at the age of 38-years-old) as dose 2 and received first dose of bnt162b2 (BNT162B2, Formulation: Solution for Injection, Batch/Lot number: ER2613) dose 1 via unknown route of administration, administered in Arm Left on 20Mar2021 2:15 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. Family medical history included daughter tested positive on 09Aug2021. The patient did not require emergency Room and physician Office for event. The patient did not received and prior vaccination within 4 weeks and list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient was tested positive for COVID 19 (vaccination failure and Covid-19) on 16Aug2021. The patient relevant tests included rapid COVID 19 test was positive on 16Aug2021. Since last night, he was very much improved. Outcome of the event was recovering.
first vaccine on 12March2021 and missed the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first vaccine on 12March2021 and missed the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first vaccine on 12March2021 and missed the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first vaccine on 12March2021 and missed the second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non-significant follow-up appended
A break-through covid inflection. Tested positive on 21Apr2022; A break-through covid inflection. Tested positive on 21Apr2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 13Dec2021 as dose number unknown (booster), single (Lot number: FD7218, Expiration Date: Feb2022) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 21Apr2022, outcome "unknown" and all described as "A break-through covid inflection. Tested positive on 21Apr2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (21Apr2022) Positive, notes: Tested positive on 21Apr2022.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a health care worker refers to a unspecified number of patients of unknown demographics. No information about medical history, concurrent conditions and concomitant medications were reported. The healthcare worker reported that VAQTA dose 0.5 ml, route intramuscular that was exposed to 0C for 30 minutes on 12-FEB-2014 had been administered to an unspecified amount of patients. No adverse effects reported. The outcome of events reported is unknown. No product quality complaint was involved. This case is linked to the case 1405USA007203, 1405USA007982, 1405USA007990, 1405USA008052 via same reporter link. Additional information has been requested.
Employee reports that 45 minutes after the H1N1 Injection (1330) she developed a "scratching feeling in the center of my chest" the developed shortness of breath and hives- presented to the ED via EMS, employee was given epi and Benadryl IV per EMS and was feeling much better upon arrival to ED at 1617. Employee continued to do well in the ED was discharged with Prednisone 20mg bid qd for 4 days at 1941.
Initial report received from a non-health care professional on 28 August 2013. A 31-year-old male patient had received first dose of IMOVAX vaccine (lot number, route of vaccination and dose number not reported, in the right forearm into wound, right deltoid) and Rabies vaccine of unknown manufacturer (lot number, route and dose number not reported) in the left deltoid, on 17 July 2013. The patient had no medical history. It was reported that the patient was bit by dog on 4 July 2013, and was recommended to take RIG and the post exposure series. On 24 July 2013, the patient had severe bradycardia to 30's and severe fatigue. The patient also had fasciculations, spasms of the right 5th finger and right forearm at IMOVAX injection site. It was reported that the symptoms were not observed every-day. Electrocardiogram was done on an unspecified date and corrective treatment was not reported. At the time of this report the events were ongoing. Documents held by sender: none.
1 year after I had COVID I was vaccinated.  I woke the day after my vaccination at 2AM with a sense of impending doom.  I was shaking like I was cold (I had a fever >100F), but I felt like my blood was fire running through my veins.  My arm was sore, I had muscle aches, and a severe headache.  I also had terrible vertigo and lost my sense of hearing for a period of time.  My symptoms lasted 24 hours, but I thought I was dying, and am very afraid to ever be vaccinated for COVID again.
Information has been received from a registered nurse concerning a 14 year old female who on an unspecified date was vaccinated with second dose of GARDASIL (dose, route and lot number not reported). The registered nurse stated that after her second dose of GARDASIL, on 02-FEB-2010, she fainted and had seizure like movements. the patient sought unspecified medical attention. Upon internal review, seizure like movements was determined to be an other important medical event. Additional information has been requested.
Child had pre-existing CNS disease; Had febrile sz 24MAR91, p/19MAR91 HIB #2; Had feb sz JUN91 p/19JUN91 HIB #3;
Myocarditis; This literature-non-study case was reported in a literature article and describes the occurrence of MYOCARDITIS (Myocarditis) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.   LITERATURE REFERENCE:     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (Myocarditis) (seriousness criterion medically significant). At the time of the report, MYOCARDITIS (Myocarditis) outcome was unknown. Related      The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.  This case belonged to adult patient 1 of 2 patients described by the reporter.  Company comment: This literature non study case concerns an adult patient of unknown age and gender, with no reported medical history, who experienced the expected, serious (medically significant) AESI of Myocarditis, unknown days after receiving an unspecified dose of mRNA-1273 vaccine. No information on risk factors, detailed clinical course, investigations including cardiac biomarkers, electrocardiography, cardiac imaging, treatment of the event, outcome and details pertaining to vaccination schedule was available in the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2022-657773 (Linked Report).; Sender's Comments: This literature non study case concerns an adult patient of unknown age and gender, with no reported medical history, who experienced the expected, serious (medically significant) AESI of Myocarditis, unknown days after receiving an unspecified dose of mRNA-1273 vaccine. No information on risk factors, detailed clinical course, investigations including cardiac biomarkers, electrocardiography, cardiac imaging, treatment of the event, outcome and details pertaining to vaccination schedule was available in the report. The benefit-risk relationship of mRNA-1273 is not affected by this report. US-MODERNATX, INC.-MOD-2022-657773:Same Article Patient 2
Chills and tiredness the day after on Sunday. Sunday evening noticed the lymph nodes in my armpit of the arm I received the shot in were swollen and sore. Still experiencing it today(Monday).
Nausea, Fever, Headache, Severe swelling in injection site, Rash on injection site.